Published 29 days ago • loading... • Updated 28 days ago

Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform - PressReach

Summary by pressreach.com

MILAN, Feb. 13, 2025 /PRNewswire/ — Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 million Series B funding round. The financing was led by a new investor, Fondazione ENEA Tech e Biomedical, with additional participation from existing investors Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital, and F3F. This significant influx of capital will empower …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All

Left

Center

Right

Silicon Canals

Italy’s Newronika raises €13.6M to build brain computers

Milan-based Newronika, a company specialising in advanced deep brain stimulation, has closed a €13.6M Series B funding round. The Italian company develops an adaptive deep brain stimulation (DBS) platform that adjusts therapy based on real-time patient data. It focuses on advancing neuromodulation beyond current methods. Neuromodulation is a treatment that uses electrical or chemical stimulation to help manage neurological disorders and enhance…

28 days ago

Read Full Article

pressreach.com

Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform - PressReach

29 days ago

Read Full Article

FinSMEs

Newronika Closes €13.6M Series B Financing

Newronika, a Milan, Italy-based deep brain stimulation company, raised €13.6M in Series B funding. The round was led by Fondazione ENEA Tech Biomedical, with additional participation from existing investors Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital, and F3F. The company intends to use the funds to expand the clinical validation and commercialization […] The post Newronika Closes €13.6M Series B Financing appeared fir…

29 days ago

Read Full Article

Medical Device Network

Newronika scoops €13.6m to support Parkinson’s DBS system development

Newronika has completed a €13.6m ($14.1m) Series B funding to advance the development of AlphaDBS, an adaptive deep brain stimulation (DBS) system for addressing the symptoms of Parkinson’s disease.The post Newronika scoops €13.6m to support Parkinson’s DBS system development appeared first on Medical Device Network.

29 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year